Nussbaum Law Group, P.C. and Roberts Law Firm US, PC Announce A $50 Million Class Action Settlement with Pfizer on Behalf of Direct Purchasers of EpiPen® or Generic EpiPen
2024年5月2日 - 11:00PM
ビジネスワイヤ(英語)
Nussbaum Law Group, P.C. and Roberts Law Firm US, PC:
COURT-ORDERED LEGAL NOTICE
UNITED
STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS
If you purchased EpiPen® or
generic EpiPen directly from the manufacturer, you may receive a
payment from a $50 million class action settlement with
Pfizer.
KPH Healthcare Services, Inc. v.
Mylan N.V.,
Case No. 2:20-cv-02065-DDC-TJJ
(District of Kansas)
This is not a recall, safety,
or other similar notice. No one is claiming that EpiPen is unsafe
or ineffective.
For more information and to
file a claim, visit www.EpiPenDPPSettlement.com.
WHAT DOES THE SETTLEMENT
PROVIDE?
A proposed settlement (“Settlement”) has
been reached in a class action lawsuit with Pfizer, Inc., Meridian
Medical Technologies, Inc., and King Pharmaceuticals, Inc. (n/k/a
King Pharmaceuticals LLC) (together, “Pfizer”). Under the
settlement, Pfizer agreed to pay $50,000,000 into a settlement fund
for the Direct Purchaser Settlement Class (“Settlement Fund”). The
lawsuit alleges that Defendants Mylan, N.V., Mylan Pharmaceuticals,
Inc., and Mylan Specialty, LP (together, “Mylan”), and Pfizer
entered into an illegal market allocation agreement with Teva
Pharmaceuticals USA, Inc. that substantially delayed the launch of
generic EpiPen and unlawfully extended Pfizer’s and Mylan’s
monopoly over the epinephrine autoinjector market. The settlement
does not resolve claims against Mylan, and the lawsuit against
Mylan will continue until it is resolved. The Court has not decided
who is right.
WHO IS INCLUDED?
People or entities who purchased EpiPen®
or generic EpiPen directly from Mylan or Teva, for resale, at any
time during the period from March 13, 2014, until the date on which
the Court entered the Preliminary Approval Order, April 3,
2024.
Excluded from the Class are Defendants and
their officers, directors, management, employees, predecessors,
subsidiaries, and affiliates, and all federal governmental
entities.
HOW CAN YOU GET A
PAYMENT?
If you are a member of the Class, you must
submit a claim form online at www.EpiPenDPPSettlement.com or by mail to get
paid. This is the only way to receive a payment.
You may have received a claim form. If
not, a claim form is available at www.EpiPenDPPSettlement.com. See the claim form
for instructions on how to submit a claim. If the Court approves
the Settlement, claims will be paid after any appeals are
resolved.
The deadline to postmark or
submit your claim online at www.EpiPenDPPSettlement.com or by email to
info@EpiPenDPPSettlement.com is
July 24, 2024.
YOUR OTHER LEGAL RIGHTS AND
OPTIONS
OBJECT
You may write to the Court about why you
do not like the Settlement, the request for attorneys’ fees,
reimbursement of expenses and costs, and service awards, and/or the
plan of allocation. If you object to the Settlement, you are still
a member of the Class and you must file a claim to receive a
payment. Objections must be filed with the Court and received by
the parties on or before May 28,
2024.
OPT OUT
You may write to the Settlement
Administrator and exclude yourself from the Class. Exclusion allows
you to file your own lawsuit. If you exclude yourself, you will not
receive any payment and will not be bound by the releases contained
in the Settlement. The exclusion deadline is May 28, 2024.
DO NOTHING
If you do nothing, you will not receive
any payment. You will still be a Class member, and therefore you
will be bound by the releases contained in the Settlement and will
not be able to file or continue to pursue your own lawsuit.
The Court scheduled a final approval
hearing for June 25, 2024, at
9:00 a.m. Central Time to consider whether the settlement
and plan of allocation are fair, reasonable, and adequate, as well
as any objections to the settlement, the plan of allocation, and
any request for attorneys’ fees, reimbursement of expenses and
costs, and service awards. You do not need to attend, but you or
your attorney can do so at your own expense.
For more information about the
Settlement and your options, please visit www.EpiPenDPPSettlement.com or call
1-866-778-6568.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240430921021/en/
Linda P. Nussbaum (917) 438-9189 lnussbaum@nussbaumpc.com
Michael L. Roberts (501) 821-5575 admin@robertslawfirm.us